Lepercq De Neuflize Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Lepercq De Neuflize Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$139K	Sell
2024 Q4	$169K	Buy